|
|
|
|
|
|
News
|
|
|
ICN2 Plasmonic Biosensor for COVID and other conditions [02-03-2022]
An innovative nano-biosensor assay for fast, quantitative and accurate COVID-19 serology, has been developed by a team of researchers led by Prof. Laura M. Lechuga, head of the NanoBiosensors and Bioanalytical Applications Group at the Catalan Institute of Nanoscience and Nanotechnology (ICN2, Barcelona, Spain). The sensor combines the high reliability of specialised laboratory analysis with the short turnaround times and simple operability of rapid self-tests.
|
|
|
Related News |
|
|
Researchers showcase new breakthroughs for unlocking the potential of plasmonics [30-01-2024]
Plasmonics |
|
|
Using AI, researchers identify a new class of antibiotic candidates that can kill a drug-resistant bacterium [20-12-2023]
Nanobiotechnology, Nanomedicine, Artificial intelligence |
|
|
Nanobots Therapeutics successfully closes a Pre-Seed funding round of €478,000 [22-09-2023]
Nanobiotechnology, Nanomedicine |
|
|
Postdoctoral fellowship for Women in Science [21-09-2023]
Nanobiotechnology, Nanotechnologies |
|
|
Precisely arranging nanoparticles [19-09-2023]
Plasmonics, Nanotechnologies |
|
|
CLOSE
|
|
|
|
|
|
|
|
|
© Phantoms Foundation 2024 |
|
